APA

Farge D., Cajfinger F., Falvo N., Berremili T., Couturaud F., Bensaoula O., Védrine L., Bensalha H., Bonnet I., Péré-Vergé D., Coudurier M., Li V., Rafii H., Benzidia I., Connors J. M. & Resche-Rigon M. (2018). Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC). : Oncotarget.

Chicago

Farge Dominique, Cajfinger Francis, Falvo Nicolas, Berremili Toufek, Couturaud Francis, Bensaoula Okba, Védrine Lionel, Bensalha Hocine, Bonnet Isabelle, Péré-Vergé Denis, Coudurier Marie, Li Veronique, Rafii Hanadi, Benzidia Ilham, Connors Jean M and Resche-Rigon Matthieu. 2018. Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC). : Oncotarget.

Harvard

Farge D., Cajfinger F., Falvo N., Berremili T., Couturaud F., Bensaoula O., Védrine L., Bensalha H., Bonnet I., Péré-Vergé D., Coudurier M., Li V., Rafii H., Benzidia I., Connors J. M. and Resche-Rigon M. (2018). Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC). : Oncotarget.

MLA

Farge Dominique, Cajfinger Francis, Falvo Nicolas, Berremili Toufek, Couturaud Francis, Bensaoula Okba, Védrine Lionel, Bensalha Hocine, Bonnet Isabelle, Péré-Vergé Denis, Coudurier Marie, Li Veronique, Rafii Hanadi, Benzidia Ilham, Connors Jean M and Resche-Rigon Matthieu. Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC). : Oncotarget. 2018.